Department of Pediatric Hematology/Oncology, King Faisal Specialist Hospital and Research Center and the King Fahad National Center for Children's Cancer, Riyadh, Saudi Arabia.
Department of Oncology, Aga Khan University, Karachi, Pakistan.
Pediatr Blood Cancer. 2019 Jun;66(6):e27684. doi: 10.1002/pbc.27684. Epub 2019 Feb 25.
Information regarding the incidence and patterns of childhood malignancies is disproportionately overrepresented by high-income countries, representing mainly the Caucasian population. There is a need to evaluate and disseminate information for other ethnicities, particularly from the Middle East.
Data from the National Cancer Registry, Saudi Arabia (SA-NCR), for pediatric patients (age 0-14 years) diagnosed between 2005 and 2009 and for similar patients at our institution during the same period were analyzed. Population numbers reported in the 2007 national census were used to calculate the annual incidence of childhood cancer.
Data from SA-NCR on 3885 patients were included in this analysis. The median age was 5.58 years, and 57.3% were males. The annual age-specific cancer incidence rate (ASR) for children in SA is 99.83 per million population; ASR per million for lymphoid leukemia is 25.75, 12.05 for brain tumors, and 9.82 for Hodgkin lymphoma. Of all childhood cancers in SA, 35% were treated at our institution. The five-year overall survival for these 1350 patients is 74.6% (median follow-up 7.52 years [95% confidence interval: 7.36-7.68]). Significant differences in the distribution of childhood malignancy subtypes were evident compared with other countries.
We have reported differences in the cancer ASR and cancer subtype distribution for children in SA as compared with the worldwide incidence and with other populations. This paper provides a comprehensive epidemiological overview of childhood cancer in SA, which could be extrapolated to other regional Arab populations.
儿童恶性肿瘤的发病情况和模式在高收入国家的数据中所占比例不成比例,这些数据主要代表白种人群。因此,有必要评估和传播其他种族的信息,特别是来自中东的信息。
分析了 2005 年至 2009 年期间在沙特阿拉伯国家癌症登记处(SA-NCR)诊断的儿科患者(0-14 岁)和同期我院类似患者的数据。使用 2007 年全国人口普查报告的人口数量来计算儿童癌症的年发病率。
本分析纳入了来自 SA-NCR 的 3885 例患者的数据。中位年龄为 5.58 岁,男性占 57.3%。沙特儿童的年发病特定癌症发病率(ASR)为每百万人口 99.83 例;淋巴白血病的 ASR 为每百万 25.75 例,脑肿瘤为 12.05 例,霍奇金淋巴瘤为 9.82 例。在沙特的所有儿童癌症中,35%在我院接受治疗。这 1350 例患者的五年总生存率为 74.6%(中位随访 7.52 年[95%置信区间:7.36-7.68])。与其他国家相比,儿童恶性肿瘤亚型的分布存在显著差异。
与全球发病率和其他人群相比,我们报告了沙特儿童的癌症 ASR 和癌症亚型分布存在差异。本文提供了沙特儿童癌症的综合流行病学概述,可以推广到其他阿拉伯地区人群。